Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Interactions and therapeutic potential of Hedgehog-Gli signaling pathway genes in ovarian tumors (CROSBI ID 561716)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa

Levanat, Sonja ; Cretnik, Maja ; Musani, Vesna ; Oreskovic, Slavko Interactions and therapeutic potential of Hedgehog-Gli signaling pathway genes in ovarian tumors // The FEBS journal / Perham, Richard (ur.). 2009. str. 68-68

Podaci o odgovornosti

Levanat, Sonja ; Cretnik, Maja ; Musani, Vesna ; Oreskovic, Slavko

engleski

Interactions and therapeutic potential of Hedgehog-Gli signaling pathway genes in ovarian tumors

The Hh-Gli signaling pathway known as Hh-Ptc or Hh/Ptc/Smo plays a major role in embryonic development and deregulated cause developmental malformations and tumorigenesis. The pathway involvement in breast, lung, prostate, digestive tract and other tumors becoming apparent recently. Normally secreted protein Hh (Hedgehog) binds to a transmembrane protein Ptc (Patched), releasing repression of Smo (Smoothened), a membrane protein, triggering a signaling cascade within the cell, finally causing expression of target genes, a tracriptional factor Gli, onvolved in cell proliferation , PTCH itself, which limits, and finally blocks the pathway, and many others. Recent findings suggest two hypothetical models of abnormal Hh-Gli pathway activation. One model (on basocellular carcinomas of ther skin (BCCs) and ovarian fibroma), suggests constitutive activation of the pathway within the cell, and doesnot require outside stimulation. The other on lung and breast tumors suggest abnormal Hh stimulation from the surrounding cells, whichcauses a strong intracellular response of the pathway. We analyzed the pathway activation on human tumors:dermoids (develop from embryonic stem cells ; they show elements of both developmental malformations and tumors) and ovarian carcinomas, by blocking and reactivating the pathway. In dermoids we showed also the role of its haploinsufficiency, while in ovarian carcinomas inactivation of the PTCH gene is mostly a consequence of deletions in first ten exons. Also, interactions with other pathways as WNT pathway are related to some extend in borderline ovarian tumors.

signaling pathway Hh-Gli ; cancer

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

68-68.

2009.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

The FEBS journal

Perham, Richard

Oxford: Wiley-Blackwell

1742-464X

1742-4658

Podaci o skupu

34th FEBS Congress

poster

04.07.2009-09.07.2009

Prag, Češka Republika

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost